Strata Critical Medical, Inc. (NASDAQ:SRTA) — Stock Price
Strata Critical Medical, Inc. (NASDAQ:SRTA) is currently trading at $5.94 USD, up 2.59% today. Over the past 52 weeks, shares have ranged between $3.99 and $6.47. This page tracks Strata Critical Medical, Inc.'s live share price on the NASDAQ exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see how much is Strata Critical Medical, Inc. worth.
Strata Critical Medical, Inc. (SRTA) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Strata Critical Medical, Inc.'s daily closing share price and trading volume on the NASDAQ exchange over the past year, giving a clear view of recent price momentum and liquidity.
Strata Critical Medical, Inc. Income Statement — Revenue, Profit & Earnings by Year
Strata Critical Medical, Inc.'s annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | $197.14 Million | $248.69 Million | $225.18 Million | $146.12 Million | $50.53 Million |
| Cost of Revenue | $156.01 Million | $189.77 Million | $183.06 Million | $123.84 Million | $40.01 Million |
| Gross Profit | $41.13 Million | $58.92 Million | $42.12 Million | $22.27 Million | $10.52 Million |
| Research & Development | $3.05 Million | $3.18 Million | $4.63 Million | $5.54 Million | $1.68 Million |
| SG&A | $60.88 Million | $81.71 Million | $95.17 Million | $62.51 Million | $30.14 Million |
| Total Operating Expenses | $63.48 Million | $92.84 Million | $110.24 Million | $75.80 Million | $34.61 Million |
| Operating Income | $-22.35 Million | $-33.93 Million | $-68.12 Million | $-53.53 Million | $-24.09 Million |
| EBITDA | $-14.17 Million | $-21.60 Million | $-50.43 Million | $-22.31 Million | $-43.10 Million |
| EBIT | $-22.35 Million | $-27.56 Million | $-57.54 Million | $-28.03 Million | $-43.70 Million |
| Interest Expense | — | — | — | — | — |
| Income Before Tax | $-20.07 Million | $-27.56 Million | $-57.54 Million | $-28.03 Million | $-43.70 Million |
| Income Tax Expense | $-61.41 Million | $-255.00K | $-1.47 Million | $-772.00K | $-3.64 Million |
| Net Income | $41.35 Million | $-27.31 Million | $-56.08 Million | $-27.26 Million | $-40.05 Million |
Strata Critical Medical, Inc. Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Strata Critical Medical, Inc.'s financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | $325.47 Million | $256.68 Million | $294.94 Million | $325.02 Million | $335.88 Million |
| Total Current Assets | $126.19 Million | $160.74 Million | $206.26 Million | $218.13 Million | $294.94 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | $30.26 Million | $108.76 Million | $138.26 Million | $150.74 Million | $279.37 Million |
| Net Receivables | $39.96 Million | $21.59 Million | $21.00 Million | $10.88 Million | $5.55 Million |
| Inventory | — | — | — | $1.13 Million | $547.00K |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | $88.21 Million | $41.05 Million | $40.37 Million | $39.45 Million | $13.33 Million |
| Total Liabilities | $46.40 Million | $34.74 Million | $60.64 Million | $50.54 Million | $44.51 Million |
| Total Current Liabilities | $19.79 Million | $22.73 Million | $35.49 Million | $26.61 Million | $12.78 Million |
| Long-term Debt | — | — | — | — | — |
| Net Debt | $-27.66 Million | $-9.06 Million | $-3.35 Million | $-23.01 Million | $-1.88 Million |
| Total Stockholder Equity | $279.07 Million | $221.94 Million | $234.30 Million | $274.49 Million | $291.37 Million |
| Retained Earnings | $-145.55 Million | $-186.90 Million | $-159.75 Million | $-103.68 Million | $-76.42 Million |
Strata Critical Medical, Inc. Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Strata Critical Medical, Inc. generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | $-48.91 Million | $-2.52 Million | $-32.35 Million | $-37.13 Million | $-15.62 Million |
| Capital Expenditures | $11.01 Million | $32.99 Million | $2.11 Million | $730.00K | $801.00K |
| Free Cash Flow | $-59.92 Million | $-35.51 Million | $-34.46 Million | $-37.86 Million | $-16.42 Million |
| Investing Cash Flow | $69.75 Million | $-1.02 Million | $17.09 Million | $79.34 Million | $-321.34 Million |
| Financing Cash Flow | $-8.91 Million | $-5.76 Million | $-76.00K | $-1.08 Million | $332.26 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | $17.83 Million | $19.89 Million | $12.50 Million | $8.28 Million | $9.62 Million |
| Depreciation | $8.19 Million | $5.96 Million | $7.11 Million | $5.72 Million | $596.00K |
| Change in Cash | $11.59 Million | $-9.37 Million | $-15.40 Million | $36.84 Million | $-4.69 Million |
Strata Critical Medical, Inc. Earnings History — EPS Actual vs. Analyst Estimates
Track Strata Critical Medical, Inc.'s quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Aug 04, 2026 | — | -0.04 | — |
| May 06, 2026 | 0.04 | -0.04 | +200.00% |
| Mar 17, 2026 | -0.12 | 0.06 | -300.00% |
| Nov 10, 2025 | -0.12 | -0.02 | -500.00% |
| Aug 05, 2025 | -0.04 | -0.05 | +20.00% |
| May 12, 2025 | -0.07 | -0.10 | +30.00% |
| Mar 13, 2025 | -0.13 | -0.12 | -10.60% |
| Nov 12, 2024 | -0.01 | -0.02 | +50.00% |